These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6350653)

  • 1. [Regulation of graft rejection using anti-lymphocyte monoclonal antibody].
    Tsuji K; Nose Y; Kusama M
    Nihon Rinsho; 1983; 41(4):834-40. PubMed ID: 6350653
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adults.
    Maraninchi D; Mawas C; Stoppa AM; Gaspard MH; Marit G; Van Ekthoven A; Reiffers J; Olive D; Hirn M; Delaage M
    Bone Marrow Transplant; 1989 Mar; 4(2):147-50. PubMed ID: 2650783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
    Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
    Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antilymphocytic antibodies and marrow transplantation. VI. Absence of immunosuppression in vivo after injection of monoclonal antibodies blocking graft-versus-host reactions and humoral antibody formation in vitro.
    Thierfelder S; Hoffmann-Fezer G; Rodt H; Doxiadis I; Eulitz M; Kummer U
    Transplantation; 1983 Mar; 35(3):249-54. PubMed ID: 6340277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
    Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A
    Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and reversal of renal allograft rejection by antibody against CD45RB.
    Lazarovits AI; Poppema S; Zhang Z; Khandaker M; Le Feuvre CE; Singhal SK; Garcia BM; Ogasa N; Jevnikar AM; White MH; Singh G; Stiller CR; Zhong RZ
    Nature; 1996 Apr; 380(6576):717-20. PubMed ID: 8614467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
    Monaco A; Goldstein G; Barnes L
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
    [No Abstract]   [Full Text] [Related]  

  • 8. Current role and status of bone marrow transplantation.
    Brenner MK; Prentice HG
    Br J Hosp Med; 1989 Mar; 41(3):260-5. PubMed ID: 2653543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two monoclonal antibodies affecting canine transplantation reactions.
    Carreno M; Esquenazi V; Olson L; Fuller L; Alejandro R; Milgrom M; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):612-4. PubMed ID: 2484197
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.
    Fischer A; Blanche S; Le Bidois J; Bordigoni P; Garnier JL; Niaudet P; Morinet F; Le Deist F; Fischer AM; Griscelli C
    N Engl J Med; 1991 May; 324(21):1451-6. PubMed ID: 2023604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of the transplant rejection reaction by manipulation of the transplants--a new model].
    Wottge HU; Müller-Ruchholtz W
    Z Exp Chir Transplant Kunstliche Organe; 1986; 19(6):346-9. PubMed ID: 3103342
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral antibody in allograft reactions.
    Winn HJ
    Transplant Proc; 1970 Mar; 2(1):83-91. PubMed ID: 4107296
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2.
    Gorczynski RM; Fu XM; Issekutz T; Cohen Z
    Cell Immunol; 1998 Feb; 184(1):74-82. PubMed ID: 9626338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression with monoclonal anti-T3 antibody (WT32) in renal transplantation.
    Tax WJ; van de Heijden HM; Willems HW; Hoitsma AJ; Berden JH; Capel PJ; Koene RA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1905-7. PubMed ID: 3274448
    [No Abstract]   [Full Text] [Related]  

  • 17. A U.S. clinical study of Orthoclone OKT3 in renal transplantation.
    Norman DJ; Shield CF; Barry J; Henell K; Funnell MB; Lemon J
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):21-7. PubMed ID: 3105136
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Kobayashi N; Nomoto K; Kong YY; Nomoto K
    Immunology; 1994 Oct; 83(2):196-204. PubMed ID: 7835935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
    Hale G; Waldmann H; Friend P; Calne R
    Transplantation; 1986 Sep; 42(3):308-11. PubMed ID: 3529531
    [No Abstract]   [Full Text] [Related]  

  • 20. The improved lytic function and in vivo efficacy of monovalent monoclonal CD3 antibodies.
    Clark M; Bindon C; Dyer M; Friend P; Hale G; Cobbold S; Calne R; Waldmann H
    Eur J Immunol; 1989 Feb; 19(2):381-8. PubMed ID: 2522881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.